Residual fragments after percutaneous nephrolithotomy.

Balkan Med J

Department of Urology, Faculty of Medicine, Trakya University, Edirne, Turkey.

Published: September 2012

AI Article Synopsis

  • Clinically insignificant residual fragments (CIRFs) are small, non-symptomatic stone remnants (≤4 mm) in the urinary system that can lead to complications like recurrent stone growth and infections despite being termed insignificant.
  • CT scans are recommended for assessing CIRFs, typically one month after treatment, unless clear imaging can be obtained immediately post-surgery.
  • Minimally invasive retrograde intrarenal surgery is considered the most effective method for addressing these residual fragments, with selective medical therapy potentially reducing future stone formation.

Article Abstract

Clinically insignificant residual fragments (CIRFs) are described as asymptomatic, noninfectious and nonobstructive stone fragments (≤4 mm) remaining in the urinary system after the last session of any intervention (ESWL, URS or PCNL) for urinary stones. Their insignificance is questionable since CIRFs could eventually become significant, as their presence may result in recurrent stone growth and they may cause pain and infection due to urinary obstruction. They may become the source of persistent infections and a significant portion of the patients will have a stone-related event, requiring auxilliary interventions. CT seems to be the ultimate choice of assessment. Although there is no concensus about the timing, recent data suggests that it may be performed one month after the procedure. However, imaging can be done in the immediate postoperative period, if there are no tubes blurring the assessment. There is some evidence indicating that selective medical therapy may have an impact on decreasing stone formation rates. Retrograde intrarenal surgery, with its minimally invasive nature, seems to be the best way to deal with residual fragments.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4115827PMC
http://dx.doi.org/10.5152/balkanmedj.2012.082DOI Listing

Publication Analysis

Top Keywords

residual fragments
12
fragments percutaneous
4
percutaneous nephrolithotomy
4
nephrolithotomy clinically
4
clinically insignificant
4
insignificant residual
4
fragments cirfs
4
cirfs described
4
described asymptomatic
4
asymptomatic noninfectious
4

Similar Publications

Background: With the emerging role of the blood biomarkers in Alzheimer's Disease (AD) clinical practice and trials, it is crucial to identify and address factors influencing the concentrations of these biomarkers in circulation for enhanced clinical utility. We aim to assess the impact of lung function on plasma AD biomarker levels and elucidate the relationship between lung function and Alzheimer's Disease and Related Dementias (ADRD).

Method: We used the Peak Expiratory Flow (PEF), plasma biomarkers of AD (Amyloid beta 42/40 (Aβ42/40) ratio, phosphorylated-tau181 (p-tau181), Neurofilament light chain (NfL) and Glial fibrillary acidic protein (GFAP)) measured in the Health and Retirement Study (HRS) 2016 survey participants (n = 3801) and incident dementia (n = 142) over 4 years.

View Article and Find Full Text PDF

Tunable mechanical properties of PDMS-TMPTMA microcapsules for controlled release in coatings.

Soft Matter

January 2025

School of Materials Engineering, Purdue University, 701 West Stadium Ave, West Lafayette, IN 47907, USA.

Within coating formulations, microcapsules serve as vehicles for delivering compounds like catalysts and self-healing agents. Designing microcapsules with precise mechanical characteristics is crucial to ensure their contents' timely release and minimize residual shell fragments, thereby avoiding adverse impacts on the coating quality. With these constraints in mind, we explored the use of 1 cSt PDMS oil as a diluent (porogen) in trimethylolpropane trimethacrylate (TMPTMA)-based to fabricate microcapsules with customized mechanical properties and submicrometer debris size after shell breakup that can encapsulate a wide range of compounds.

View Article and Find Full Text PDF

Human infection with Cuterebra species is the most common form of endemic myiasis in North America. The authors present a case of a `12-year-old female with left upper eyelid swelling 1 week after visiting a petting farm in Manitoba. A larva was removed with forceps through an eyelid skin pore and identified as Cuterebra sp.

View Article and Find Full Text PDF

Stone-event-free survival after retrograde intrarenal surgery: is the stone-free-status so relevant for the future outcomes?

Int Urol Nephrol

December 2024

Department of Urology, Unidade Local de Saúde de Santo António, Centro Hospitalar Universitário Do Porto, 8th floor, Largo Do Prof. Abel Salazar, 4099-001, Porto, Portugal.

Introduction: The primary aim of stone treatment is to achieve stone-free status. Residual fragments can cause stone growth, recurrence, urinary tract infections, and ureteric obstruction. Our goal was to describe the natural history of stone burden after retrograde intrarenal surgery (RIRS) based on stone-free status (SFS), evaluating stone growth and stone-events.

View Article and Find Full Text PDF

Purpose: To evaluate stone free rate (SFR) predictivity of three different scoring systems in patients with kidney stones larger than 20 millimeters undergoing retrograde intrarenal surgery(RİRS).

Methods: Digital records of a total of 166 patients were reviewed retrospectively. Epidemiological characteristics (age, gender, medical history) of the patients, stone and affected kidney characteristics (size, volume, location, density, opaque, presence of urinary system anomaly, presence of stones in different calyx, number of stones, lower pole stone, renal infundibulopelvic angle (IPA), renal infundibulopelvic length (RIL), hydronephrosis), and operative characteristics (preoperative ureteral stent, operation duration, postoperative residual fragments, hospitalization time and complications were recorded.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!